Oophorectomy, menopause, estrogen, and cognitive aging: The timing hypothesis

Neurodegenerative Diseases

Volumn 7, Issue 1-3, 2010, Pages 163-166

  Rocca, Walter A ^a,b   Grossardt, Brandon R ^b   Shuster, Lynne T ^c  

^a MAYO CLINIC   (United States)

^b Department of Neurology ^*  (United States)

^c Department of Internal Medicine   (Australia)

Author keywords

Cognitive impairment; Dementia; Estrogen; Menopause; Neuroprotection; Oophorectomy; Timing hypothesis

Indexed keywords

ESTROGEN;

AGING; BRAIN PROTECTION; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GROUPS BY AGE; HUMAN; HYPOTHESIS; MENOPAUSAL SYNDROME; MENOPAUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RISK FACTOR;

AGING; COGNITION DISORDERS; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; NEUROPROTECTIVE AGENTS; OVARIECTOMY; WOMEN'S HEALTH;

EID: 77449147924     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000289229     Document Type: Conference Paper

References (20)

1. Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro N: Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006; 13: 139-147.
2. Siegfried T: Neuroscience: it's all in the timing. Nature 2007; 445: 359-361.
3. McEwen BS, Alves SE: Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307.
4. Monk D, Brodaty H: Use of estrogens for the prevention and treatment of Alzheimer's disease. Dement Geriatr Cogn Disord 2000; 11: 1-10.
5. Gibbs RB, Aggarwal P: Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 1998; 34: 98-111.
6. Markowska AL, Savonenko AV: Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 2002; 22: 10985-10995.
7. Huang J, Guan H, Booze RM, Eckman CB, Hersh LB: Estrogen regulates neprilysin activity in rat brain. Neurosci Lett 2004; 367: 85-87.
8. Morrison JH, Brinton RD, Schmidt PJ, Gore AC: Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006; 26: 10332-10348.
9. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd: Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007; 69: 1074-1083.
10. Shuster LT, Gostout BS, Grossardt BR, Rocca WA: Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int 2008; 14: 111-116.
11. Rocca WA, Shuster LT, Grossardt BR, Maraganore DM, Gostout BS, Geda YE, Melton LJ 3rd: Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) 2009; 5: 39-48.
12. Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K: Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev 2008: CD003122.
13. LeBlanc ES, Janowsky J, Chan BK, Nelson HD: Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285: 1489-1499.
14. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E: Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 1999; 52: 965-970.
15. Zandi PP, Carlson MC, Plassman BL, Welsh- Bohmer KA, Mayer LS, Steffens DC, Breitner JC: Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002; 288: 2123-2129.
16. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-2958.
17. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651-2662.
18. Buist DS, Newton KM, Miglioretti DL, Beverly K, Connelly MT, Andrade S, Hartsfield CL, Wei F, Chan KA, Kessler L: Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004; 104: 1042-1050.
19. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K: Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004; 140: 184-188.
20. Hersh AL, Stefanick ML, Stafford RS: National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291: 47-53.